Skip to main content
. 2014 Sep 21;20(35):12588–12594. doi: 10.3748/wjg.v20.i35.12588

Figure 1.

Figure 1

Flow diagram shows algorithm of enrolled patients. Ninety-four patients were analyzed for this study who are alive without recurrence of HCC at 1 year after combination of TACE+RFA. HCC: Hepatocellular carcinoma; intra-OP: Intra-operative; RFA: Radiofrequency ablation; RT: Radiation therapy; TACE: Transcatheter arterial chemoembolization.